SCL-90-R Symptom Profiles and Outcome of Short-Term Psychodynamic Group Therapy
Table 1
Present pre- and posttreatment means (SD), and Jacobson and Truax change status groups of target symptoms and GSI for the four major target groups. Groups are arranged according to percent of patients who remitted in target pathology.
Mean (SD) scores
Jacobson and Truax outcome groups
Total
Pretreatment
Posttreatment
No change
Reliable change
Clinical significant change
SCL-90-R target symptoms
Interpersonal sensitivity
2.44 (.53)
1.51 (.74)
37.5% (15)
22.5% (9)
40.0% (16)
40
Depression
2.67 (.53)
1.98 (.85)
43.5% (53)
27.0% (33)
29.5% (36)
122
Anxiety
2.38 (.54)
1.64 (.62)
36.4% (16)
47.7% (21)
15.9% (7)
44
Phobic anxiety
3.22 (.58)*
2.05 (.99)
13.0% (3)
87.0% (20)
0.0% (0)
23
SCL-90-R global severity (GSI)
Interpersonal sensitivity
1.56 (.43)
1.04 (.50)
22.5% (9)
37.5% (15)
40.0% (16)
40
Depression
1.75 (.47)
1.34 (.64)
35.2% (43)
34.4% (42)
30.3% (37)
122
Anxiety
1.64 (.51)
1.29 (.59)
40.9% (18)
38.6% (17)
20.5% (9)
44
Phobic anxiety
1.82 (.47)
1.37 (.61)
26.1% (6)
47.8% (11)
26.1% (6)
23
Total sample
Target symptom improvement
2.63 (.58)
1.84 (.83)
38.0% (87)
36.2% (83)
25.8% (59)
229
Global severity index (GSI)
1.70 (.47)
1.28 (.61)
33.2% (76)
37.1% (85)
29.7% (68)
229
*pretreatment score is significantly different from the remaining sample (one-way ANOVA, Tukey post hoc test).
